These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29382237)

  • 1. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.
    Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F
    Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain distribution of ribavirin after intranasal administration.
    Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
    Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary microparticles and agglomerates of morphine for nasal insufflation.
    Russo P; Sacchetti C; Pasquali I; Bettini R; Massimo G; Colombo P; Rossi A
    J Pharm Sci; 2006 Dec; 95(12):2553-61. PubMed ID: 16937333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats.
    Balducci AG; Ferraro L; Bortolotti F; Nastruzzi C; Colombo P; Sonvico F; Russo P; Colombo G
    Int J Pharm; 2013 Jan; 440(2):154-60. PubMed ID: 23046665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation.
    Tiozzo Fasiolo L; Manniello MD; Banella S; Napoli L; Bortolotti F; Quarta E; Colombo P; Balafas E; Kostomitsopoulos N; Rekkas DM; Valsami G; Papakyriakopoulou P; Colombo G; Russo P
    Int J Pharm; 2021 Aug; 605():120827. PubMed ID: 34171428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
    Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
    J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
    Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
    Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine microparticles for nasal administration obtained by spray drying.
    Sacchetti C; Artusi M; Santi P; Colombo P
    Int J Pharm; 2002 Aug; 242(1-2):335-9. PubMed ID: 12176274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
    Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
    Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
    Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
    Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Curr Drug Deliv; 2012 Mar; 9(2):205-18. PubMed ID: 22023210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.
    Papakyriakopoulou P; Manta K; Kostantini C; Kikionis S; Banella S; Ioannou E; Christodoulou E; Rekkas DM; Dallas P; Vertzoni M; Valsami G; Colombo G
    Int J Pharm; 2021 Sep; 607():121016. PubMed ID: 34411652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
    Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
    Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of nasal powders of beta-cyclodextrin by insufflation.
    De Ascentiis A; Bettini R; Caponetti G; Catellani PL; Peracchia MT; Santi P; Colombo P
    Pharm Res; 1996 May; 13(5):734-8. PubMed ID: 8860429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain uptake of an anti-ischemic agent by nasal administration of microparticles.
    Dalpiaz A; Gavini E; Colombo G; Russo P; Bortolotti F; Ferraro L; Tanganelli S; Scatturin A; Menegatti E; Giunchedi P
    J Pharm Sci; 2008 Nov; 97(11):4889-903. PubMed ID: 18300305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.